<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03835039</url>
  </required_header>
  <id_info>
    <org_study_id>5120</org_study_id>
    <nct_id>NCT03835039</nct_id>
  </id_info>
  <brief_title>The Ability of NIRS to Predict Brain Injury in Hypoxic Ischemic Encephalopathy</brief_title>
  <official_title>The Ability of Near Infrared Spectroscopy Monitoring During Hypothermia Treatment to Predict Brain Injury in Infants With Hypoxic Ischemic Encephalopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Albany Medical College</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medtronic</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Albany Medical College</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A longitudinal study evaluating the predictive ability of near infrared spectroscopy to
      predict brain injury in infants with hypoxic ischemic encephalopathy. Data will be analyzed
      at two different time periods, at discharge and again at 2 years of age.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 3, 2019</start_date>
  <completion_date type="Anticipated">January 1, 2026</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>MRI findings of encephalopathy</measure>
    <time_frame>6 days</time_frame>
    <description>MRI studies will be reviewed and assessed for markers of HIE including damage to deep grey matter structures.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neurodevelopment at 2 years of age</measure>
    <time_frame>2 years</time_frame>
    <description>Bayleys developmental test will be used to categorize the infants' neurodevelopment at 2 years of age.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>HIE - Perinatal Hypoxic - Ischemic Encephalopathy</condition>
  <arm_group>
    <arm_group_label>HIE</arm_group_label>
    <description>Infants with a diagnosis of HIE</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NIRS</intervention_name>
    <description>Monitoring cerebral and perirenal perfusion using NIRS</description>
    <arm_group_label>HIE</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Newborn infants with diagnosis of HIE
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants with diagnosis at birth of HIE

        Exclusion Criteria:

          -  none
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>2 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kate Tauber, MD</last_name>
    <phone>5182621784</phone>
    <email>tauberk@amc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Albany Medical Center Neonatal Intesive Care Unit</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kate A Tauber, MD</last_name>
      <phone>518-262-5421</phone>
      <email>tauberk@mail.amc.edu</email>
    </contact>
    <investigator>
      <last_name>Kate A Tauber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>January 18, 2019</study_first_submitted>
  <study_first_submitted_qc>February 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 8, 2019</study_first_posted>
  <last_update_submitted>July 9, 2020</last_update_submitted>
  <last_update_submitted_qc>July 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Hypoxia-Ischemia, Brain</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

